• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchPhio Pharmaceuticals
    Picture of Phio Pharmaceuticals logo

    PHIO — Phio Pharmaceuticals News Story

    $0.850.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $9.90m
    • Enterprise Value
      -$3.09m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PHIO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PHIO Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:00 PM

    Picture of Phio Pharmaceuticals logoPhio Pharmaceuticals
    08/04/2022 18:01
    NASDAQ TRADE HALT  PHIO.O  VOLATILITY TRADING PAUSE AT 01:00 PM
    

    Recent news on Phio Pharmaceuticals

    See all news
    • Phio Pharmaceuticals Q1 net loss widens on higher R&D costs

      07/05/2026 21:57
    • Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026

      08/04/2026 22:10
    • Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial

      20/01/2026 16:05
    • Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing

      23/12/2025 14:01
    • Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing

      20/11/2025 21:44

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.